Who we are?

Founded in 2022, Porton PharmaTech, Slovenia is the European subsidiary of Porton Pharma Solutions Ltd. It is the first CDMO in the pharmaceutical industry in Slovenia, dedicated to providing comprehensive services to Customers, encompassing synthesis route development, process familiarization, development & characterization, analytical methods development & validation, followed by right-first-time process scale up in production facilities.

At Porton PharmaTech, d.o.o. customers are fully supported by an integrated project team committed to deliver services and products within expected timelines, quantity and quality.

Mission
& Vision

Enabling the public's early acces to good medicines.

Values

Customer First
Teamwork
Efficienct Execution
Embrace Changes
Pursuit of Excellence

Our Journey To Excellence

2022

Porton PharmaTech, d.o.o. founded

2023

First 30 employees joined the company, 2 R&D teams were formed, construction of Pilot plant was started

2024

State-of-the-art R&D laboratories & kilo-laboratory were finished

A Customer-centric, Innovative and Reliable CDMO with Global Solutions

Our global network

We have 4300+ skilled employees working across 20+ sites around the globe

As a global provider of CDMO solutions, Porton has more than 20+ sites across US, EU and China. We strive to establish a versatile high-standard R&D and production platform and to constantly enrich and strengthen curability to provide efficient and reliable CDMO services to pharma and biotech customers around the world.